T10	Subject 2 26	69-year-old white female
T13	Effect 186 219	elevated INR of greater than 12.3
T15	Treatment 33 128;228 325	anticoagulation treatment had been stable for 18 months with warfarin 2.5 mg daily (17.5 mg/wk) dose increase in extended-release niacin (Niaspan) from 500 mg to 1000 mg daily the previous week
T16	Age 2 13	69-year-old
T17	Race 14 19	white
T18	Gender 20 26	female
T19	Drug 245 268	extended-release niacin
T21	Dosage 294 301	1000 mg
T22	Freq 302 307	daily
T23	Drug 94 102	warfarin
T24	Dosage 103 109	2.5 mg
T25	Freq 110 115	daily
T14	Severity_cue 175 185	critically
T12	Adverse_event 220 225	after
T26	Combination 242 244	in
E1	Adverse_event:T12 
E2	Combination:T26 arg:T19 arg2:T23
A1	Severity E1 High
